| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 685285 | Null | 0.0321614375606959 | 0.11905258 |
| NSC 699934 | Null | 0.0321614375606959 | 0.5297172 |
| NSC 700862 | 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- | 0.0321614375606959 | 0.51497799 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0321614375606959 | -0.11090813 |
| NSC 734287 | 6-(3-Aminopropyl)-5,6-dihydro-7,8,9-trimethoxy-3-nitro-5,11- dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.0321614375606959 | 0.15655529 |
| NSC 741425 | 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide | 0.0321614375606959 | 0.31897498 |
| NSC 753598 | Null | 0.0321614375606959 | 0.29012837 |
| NSC 762346 | Null | 0.0321614375606959 | 0.11237559 |
| NSC 762901 | trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide | 0.0321614375606959 | 0.1568122 |
| NSC 92207 | Null | 0.0321614375606959 | 0.28589103 |